The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEe{open}4, and age of dementia onset

Neurobiology of Aging

Volumn 31, Issue 6, 2010, Pages 910-916

  Gustafson, D R ^a,b   Melchior, L ^a   Eriksson, E ^a   Sundh, V ^a   Blennow, K ^a   Skoog, I ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin converting enzyme; Body mass index; Dementia; Epidemiology; Genotype; Hip circumference; Phenotype; Polymorphism; Renin angiotensin system; Waist circumference

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4; DIPEPTIDYL CARBOXYPEPTIDASE; RAS PROTEIN;

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; ENZYME POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INDEL MUTATION; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; METABOLIC BALANCE; ONSET AGE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SAMPLE SIZE; SWEDEN; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METABOLIC DISEASES; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEX FACTORS; SWEDEN;

EID: 77951975816     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.07.015     Document Type: Article

References (37)

1. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., Chai S.Y. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 2001, 276(52):48623-48626.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1987, American Psychiatric Association, Washington, DC. 3rd revised ed.
3. Åsberg M., Perris C., Schalling D., Sedvall G. The CPRS - development and applications of a psychiatric rating scale. Acta Psychiatr. Scand. 1978, (Suppl. 271).
4. Barley J., Blackwood A., Carter N.D., Crews D.E., Cruickshank J.K., Jeffery S., Ogunlesi A.O., Sagnella G.A. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J. Hypertens. 1994, 12(8):955-957.
5. Barrett-Connor E., Edelstein S.L., Corey-Bloom J., Wiederholt W.C. Weight loss precedes dementia in community-dwelling older adults. J. Am. Geriatr. Soc. 1996, 44:1147-1152.
6. Barton M., Carmona R., Ortmann J., Krieger J.E., Traupe T. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int. J. Biochem. Cell. Biol. 2003, 35(6):826-837.
7. Bengtsson C., Ahlquist M., Andersson K., Björkelund C., Lissner L., Söderström M. The prospective population study of women in Gothenburg, Sweden, 1968-69 to 1992-93. A 24-year follow-up study with special reference to participation, representativeness, and mortality. Scand. J. Primary Health Care 1997, 15:214-219.
8. Bengtsson C.L., Hallberg H., Noppa H., Tibblin E. Anthropometric data in middle-aged women. The population study of women in Göteborg 1968-1969. Acta Morphol. Neerl. Scand. 1979, 17:133.
9. Blennow K., Ricksten A., Prince J.A., Brookes A.J., Emahazion T., Wasslavik C., Bogdanovic N., Andreasen N., Batsman S., Marcusson J., Nagga K., Wallin A., Regland B., Olofsson H., Hesse C., Davidsson P., Minthon L., Jansson A., Palmqvist L., Rymo L. No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J. Neural. Transm. 2000, 107:1065-1079.
10. Buchman A.S., Wilson R.S., Bienias J.L., Shah R.C., Evans D.A., Bennett D.A. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005, 65(6):892-897.
11. Cambien F., Alhenc-Gelas F., Herbeth B., Andre J.L., Rakotovao R., Gonzales M.F., Allegrini J., Bloch C. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am. J. Hum. Genet. 1988, 43(5):774-780.
12. Elkins J.S., Douglas V.C., Johnston S.C. Alzheimer disease risk and genetic variation in ACE: a meta-analysis. Neurology 2004, 62(3):363-368.
13. Goossens G.H., Blaak E.E., van Baak M.A. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes. Rev. 2003, 4(1):43-55.
14. Gustafson D. A life course of adiposity and dementia. Eur. J. Pharmacol. 2008, 585(1):163-175.
15. Gustafson D.R., Rothenberg E., Blennow K., Steen B., Skoog I. An 18-year follow up of overweight and risk for Alzheimer's disease. Arch. Intern. Med. 2003, 163:1524-1528.
16. Hanon O., Seux M.L., Lenoir H., Rigaud A.S., Forette F. Prevention of dementia and cerebroprotection with antihypertensive drugs. Curr. Hypertens. Rep. 2004, 6(3):201-207.
17. Hemming M.L., Selkoe D.J. Amyloid beta -protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J. Biol. Chem. 2005, 280(45):37644-37650.
18. Hu J., Igarashi A., Kamata M., Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J. Biol. Chem. 2001, 276(51):47863-47868.
19. Katzov H., Bennet A.M., Kehoe P., Wiman B., Gatz M., Blennow K., Lenhard B., Pedersen N.L., deFaire U., Prince J.A. A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Hum. Mol. Genet. 2004, 13:2647-2657.
20. Kehoe P.G., Wilcock G.K. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?. Lancet Neurol. 2007, 6(4):373-378.
21. Lee Y.H., Tharp W.G., Maple R.L., Nair S., Permana P.A., Pratley R.E. Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity 2008, 16(7):1493-1500.
22. Lehmann D.J., Cortina-Borja M., Warden D.R., Smith A.D., Sleegers K., Prince J.A., van Duijn C.M., Kehoe P.G. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am. J. Epidemiol. 2005, 162(4):305-317.
23. Oba R., Igarashi A., Kamata M., Nagata K., Takano S., Nakagawa H. The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide. Eur. J. Neurosci. 2005, 21(3):733-740.
24. Olsson M., Annerbrink K., Westberg L., Melke J., Baghaei F., Rosmond R., Holm G., Andersch S., Allgulander C., Eriksson E. Angiotensin-related genes in patients with panic disorder. Am J Med Genet Pt B 2004, 127B(1):81-84.
25. Palsson S., Larsson L., Tengelin E., Waern M., Samuelsson S., Hallstrom T., Skoog I. The prevalence of depression in relation to cerebral atrophy and cognitive performance in 70- and 74-year-old women in Gothenburg. The Women's Health Study. Psychol. Med. 2001, 31:39-49.
26. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Madseu J.C., Garcia J.H., Amaducci L., Orgogozo J.-M., Brun A., Hofman A., Moody D.M., O'Brien M.D., Yamaguchi T., Grafman J., Drayer B.P., Bennett D.A., Fisher M., Ogata J., Kokmen E., Bermejo F., Wolf P.A., Gorelick P.B., Bick K.L., Pajeau A.K., Bell M.A., DeCarli C., Culebras A., Korczyn A.D., Bogousslavsky J., Hartmann A., Scheinberg P. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260.
27. Savaskan E. The role of the brain renin-angiotensin system in neurodegenerative disorders. Curr. Alzheimer Res. 2005, 2(1):29-35.
28. Skoog I. Psychiatric epidemiology of old age: the H70 study-the NAPE lecture 2003. Acta Psychiatr. Scand. 2004, 109(1):4-18.
29. Skoog I., Andresson L.-A., Palmertz B., Landahl S., Lernfelt B. A population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension 1998, 32:404-409.
30. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., Persson G., Oden A., Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141-1145.
31. Skoog I., Nilsson L., Palmertz B., Andreasson L.-A., Svanborg A. A population-based study of dementia in 85-year-olds. N. Engl. J. Med. 1993, 328:153-158.
32. Sleegers K., denHeijer T., vanDijk E.J., Hofman A., Bertoli-Avella A.M., Koudstaal P.J., Breteler M.M.B., VanDuijn C.M. ACE gene is associated with Alzheimer's disease and atrophy of the hippocampus and amygdala. Neurobiol. Aging 2005, 26:1153-1159.
33. Steen B., Djurfeldt H. The gerontological and geriatric population studies in Gothenburg, Sweden. Z. Gerontol. 1993, 26:163-169.
34. Stewart R., Masaki K., Xue Q.L., Peila R., Petrovitch H., White L.R., Launer L.J. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch. Neurol. 2005, 62(1):55-60.
35. Strazzullo P., Iacone R., Iacoviello L., Russo O., Barba G., Russo P., D'Orazio A., Barbato A., Cappuccio F.P., Farinaro E., Siani A. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann. Intern. Med. 2003, 138(1):17-23.
36. Tzourio C. Vascular factors and cognition: toward a prevention of dementia?. J. Hypertens. Suppl. 2003, 21(Suppl. 5):S15-S19.
37. Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res. 2007, 4(2):103-109.